Non-Alcoholic Fatty Liver Disease Trial, Recruiting NCT06888310 Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS Condition: Non-Alcoholic Fatty Liver Disease
Back to Non Alcoholic Fatty Liver Disease

Non-Alcoholic Fatty Liver Disease Trial, Recruiting

NCT06888310
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older (any sex)
  • You have been diagnosed with a liver disease related to metabolic problems (such as fatty liver disease linked to obesity, diabetes, or similar conditions), based on the latest medical definitions
  • A special ultrasound scan of your liver (called a FibroScan or similar test) has shown a result suggesting your liver may have significant scarring (a score of 10 or higher)
  • You have had a camera test to look inside your food pipe and stomach (an endoscopy) within the last 12 months, which checked for enlarged, at-risk veins in those areas

Who may not be able to join:

  • You have a blood clot in the main vein that supplies your liver (portal vein thrombosis)
  • You have a type of liver cancer or tumour that spreads through the liver tissue (infiltrative liver neoplasm)
  • You have a heart condition that causes blood to back up into the liver (congestive liver disease)
  • You have a blockage in the bile ducts outside the liver (extrahepatic biliary obstruction)
  • Your liver inflammation levels (a blood test called ALT) are more than 5 times higher than the normal upper limit, as this can affect the accuracy of the liver scan results

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luca Miele, Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phone: +390630157717

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
6 December 2024
Est. completion
1 December 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

number of patients identified with single diagnostic method

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov